FutureCare Studies is a private clinical research facility serving Western New England in the conduction of clinical trials since 1996 and is dedicated solely to this purpose.   

Since its inception, FutureCare Studies has experienced strong growth, having performed studies for a number of pharmaceutical companies across an increasing variety of therapeutic areas. These companies include some of the most respected in the industry, including:

Pharmaceutical Companies

Abbott    Merck   AstraZeneca   Novartis   Bayer   Pharmacia   Boehringer Ingelheim   Pfizer   Bristol-Myers Squibb   TAP Pharmaceuticals   GlaxoSmithKline   Roche   Lilly   Searle   MedImmune   Solvay

The majority of our clinical research studies investigate the effectiveness of not-yet FDA approved medications, or new doses or formulations of previously approved medications. This method of drug testing is the only scientific method to prove safety and effectiveness for the medical compound in development.

Future Care Studies is licensed in the state of Massachusetts to conduct clinical research and has dedicated and experienced research doctors and nurses.

All clinical testing performed is conducted within FDA guidelines and follows a stringent research protocol.